Caris Life Sciences, Inc. (CAI)
14.56
-0.69
(-4.52%)
USD |
NASDAQ |
May 15, 16:00
14.75
+0.19
(+1.30%)
After-Hours: 20:00
Caris Life Sciences Market Cap : 4.108B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Neurocrine Biosciences, Inc. | 15.93B |
| Nuvalent, Inc. | 8.091B |
| Alnylam Pharmaceuticals, Inc. | 38.30B |
| Glaukos Corp. | 8.458B |
| CytomX Therapeutics, Inc. | 785.91M |
Market Cap Related Metrics
| PS Ratio | 4.527 |
| PEG Ratio | -0.9048 |
| Price to Book Value | 6.922 |
| Price to Free Cash Flow | 35.48 |
| Price | 14.56 |
| Earnings Yield | -10.07% |
| PEGY Ratio | -0.9048 |
| Operating PE Ratio | 37.91 |